Katherine A. High
KA
Co-founder
路 Philadelphia, United States
Katherine A. High
Co-founder
About
Co-founder and Head of R&D/Chief Scientific Officer of Spark Therapeutics gene therapy company. Acquired by Roche for $4.3B in 2019. Director of Center for Cellular and Molecular Therapeutics at Children's Hospital Philadelphia.
Score Breakdown
91Influence
33Track Record
89Visibility
0Profile
50Community
0Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
Who is Katherine A. High?
Co-founder and Head of R&D/Chief Scientific Officer of Spark Therapeutics gene therapy company. Acquired by Roche for $4.3B in 2019. Director of Center for Cellular and Molecular Therapeutics at Children's Hospital Philadelphia.
What is Katherine A. High's current role?
Katherine A. High is currently Co-founder.
Where is Katherine A. High based?
Katherine A. High is based in Philadelphia, United States.
Contact Info
Similar People